Tesla (TSLA) shares are down on Thursday as investors react to the EV company’s weak Q1 delivery numbers, concerns over U.S.
“We are thrilled to introduce Toll Brothers at Nolte Farms to the Seguin community,” said Matt Foran, Division President of ...
DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America. DIV’s objective is to acquire ...
With 93% of team members agreeing that Credit Acceptance is a great place to work, the Company is continuously ranked as one of the best places to work. We remain committed to fostering an environment ...
Trump Media & Technology Group Corp. (DJT) saw its stock tumble by 4% to $17.93 on April 3, 2025, following President Trump’s ...
Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that its Board of Directors (the “Board”) has ...
MIAMI, April 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) announced that it will report results for the second fiscal quarter ended March 31, 2025 ...
MIAMI, April 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) announced that it will report results for the second fiscal quarter ended March 31, 2025 on ...
Vaidio’s winning 9th generation platform features powerful agentic intelligence and GenAI capabilities. A new camera auto-configuration agent uses the latest vision language models (VLMs) to automate ...
Attr a ct i v e T ax- R e du ct i o n B e n e f its Flow-through partnerships are one of the most effective tax reduction strategies available to Canadians. Ninepoint anticipates that investors ...
Presentations & Reports within the Investors section of the Company website TFI International Inc. is a North American leader in the transportation and logistics industry, operating across the United ...
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results